On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on Press Releases and More with NNW Prime! Click to View Details

NetworkNewsBreaks – Teewinot Life Sciences Produces Cannabinoids through Patent-protected CANNSYNTHESIS Technology

Cannabinoid-based pharmaceuticals company Teewinot Life Sciencess employs its patent-protected CANNSYNTHESIS® technology to biosynthesize cannabinoids for the large-scale manufacture of pharmaceutically pure cannabinoids. An article discussing the company’s technology reads: “Apart from THC and CBD, many of the 111 or so cannabinoids found in the cannabis plant are produced in minute quantities. Production by extraction is … Continue reading “NetworkNewsBreaks – Teewinot Life Sciences Produces Cannabinoids through Patent-protected CANNSYNTHESIS Technology”

NetworkNewsBreaks – Teewinot Life Sciences Lowers Production Cost of Clinical-Grade Cannabinoids with Proprietary Synthetic Biology Technology

Teewinot Life Sciences is on a mission to cut costs of cannabinoid production while approaching the process like a pharmaceutical company, not as a cannabis firm. An article discussing the company reads: “Teewinot Life Sciences is a Tampa, Florida-based global biopharmaceutical company focused on cannabinoid clinical development utilizing patented and proprietary synthetic biology and biocatalysis … Continue reading “NetworkNewsBreaks – Teewinot Life Sciences Lowers Production Cost of Clinical-Grade Cannabinoids with Proprietary Synthetic Biology Technology”

Teewinot Life Sciences Corporation is Producing Cannabinoids without Touching the Plant

Producing cannabinoids through biosynthesis CANNSYNTHESIS® platform has capacity to scale up Revenues from out-licensing technology For the half a billion or so who suffer from one type or another of diabetes, biosynthesis offers a lifeline. For it is through biosynthesis that much of the world’s insulin is produced. Insulin regulates the metamorphosis of fats and … Continue reading “Teewinot Life Sciences Corporation is Producing Cannabinoids without Touching the Plant”

Teewinot Life Sciences’ Patented Biosynthetic Tech Cuts Costs and Produces Clinical-Grade Cannabinoids

Company’s IP portfolio, including proprietary technology and biosynthetic methods, features seven U.S. patents and patent filings in numerous other key countries around the world Eliminating the high costs of cultivating plants, Teewinot Life Sciences Corporation delivers pure, consistent pharmaceutical-grade cannabinoids Company’s goal is to cut costs and approach cannabinoid production like a pharmaceutical company, not … Continue reading “Teewinot Life Sciences’ Patented Biosynthetic Tech Cuts Costs and Produces Clinical-Grade Cannabinoids”

NetworkNewsAudio – Teewinot Life Sciences Corporation Interview

About Teewinot Life Sciences Teewinot Life Sciences is an international biopharmaceutical company employing its patent-protected CannSynthesis® technology to biosynthesize cannabinoids for the large-scale manufacture of pharmaceutically pure cannabinoids including the varin series of compounds, which are only found in relatively small quantities in the cannabis plant. Teewinot’s focus is on the biosynthetic production of pure, … Continue reading “NetworkNewsAudio – Teewinot Life Sciences Corporation Interview”

NetworkNewsBreaks – Teewinot Life Sciences Subsidiary Granted New Broad Claiming U.S. Patent

Cannabinoid-based pharmaceuticals company Teewinot Life Sciences, along with its wholly-owned Irish subsidiary, Teewinot Technologies, Ltd., this morning announced the grant of U.S. Patent No. 9,879,292. The newly granted patent covers biosynthetic production of cannabinoids and cannabinoid analogs. “We are happy to announce the continued expansion of our valuable patent portfolio. Our technology platform enables standardized … Continue reading “NetworkNewsBreaks – Teewinot Life Sciences Subsidiary Granted New Broad Claiming U.S. Patent”

NetworkNewsBreaks – Teewinot Life Sciences Positioned as Major Player in the Manufacture, Delivery of Cannabinoids Products

Cannabinoid-based pharmaceuticals company Teewinot Life Sciences Corporation has created patent protected methods to produce exact cannabinoid molecules called CANNSYNTHESIS®. An article discussing the company reads: “To protect this invaluable asset, Teewinot has taken aggressive intellectual property protection actions and filed patent applications in key countries around the world. Teewinot has created an exceptional combination of … Continue reading “NetworkNewsBreaks – Teewinot Life Sciences Positioned as Major Player in the Manufacture, Delivery of Cannabinoids Products”

Teewinot Life Sciences Corporation: At the Vanguard of Biopharmaceutical Cannabinoid Therapeutics

Global medicinal cannabinoid market to exceed $55 billion by 2025 Teewinot has created patent protected methods to produce exact cannabinoid molecules called CANNSYNTHESIS® Efficient cost-effective methods reduce production time and increase purity There is indisputable scientific evidence of the curative effects of cannabinoids, and specialty biopharmaceutical companies are positioning to capitalize on the explosive growth … Continue reading “Teewinot Life Sciences Corporation: At the Vanguard of Biopharmaceutical Cannabinoid Therapeutics”

NetworkNewsBreaks – Teewinot Life Sciences Corporation Awarded Broad US Patent

Cannabinoid-based pharmaceuticals company Teewinot Life Sciences Corporation this morning announced that it has been granted U.S. Patent No. 9,861,609. Per the update, the newly-issued patent has broad claims to biosynthetic methods for the pharmaceutical manufacture of cannabinoids and cannabinoid analogs. “With the grant of the ‘609 patent, Teewinot has now secured six U.S. patents covering … Continue reading “NetworkNewsBreaks – Teewinot Life Sciences Corporation Awarded Broad US Patent”

Teewinot Life Sciences is “One to Watch”

Holds 6 U.S. patents covering biosynthesis of cannabinoids, including first U.S. issued patent to create water-soluble cannabinoids Aggressively seeking intellectual property patent protection in key countries worldwide Able to manufacture kilogram quantities of 18 naturally occurring cannabinoids through biosynthetic processes Canadian subsidiary holds controlled substances license from Health Canada Teewinot Life Sciences is an international … Continue reading “Teewinot Life Sciences is “One to Watch””

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 212.418.1217